These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25497511)

  • 1. QTc prolongation and haloperidol: just how risky is this drug?
    Howland RH
    Psychosomatics; 2014; 55(6):741-2. PubMed ID: 25497511
    [No Abstract]   [Full Text] [Related]  

  • 2. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
    Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consideration of the JT interval rather than the QT interval.
    Salik J; Muskin PR
    Psychosomatics; 2013; 54(5):502. PubMed ID: 24034531
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolongation of QTc interval and antipsychotics.
    Su KP; Chang HC; Shen WW
    Am J Psychiatry; 2002 Jun; 159(6):1062-3; author reply 1064. PubMed ID: 12042204
    [No Abstract]   [Full Text] [Related]  

  • 5. Probable Acquired QTc Prolongation and Subsequent Torsades de Pointes Attributable to Quetiapine.
    Giancaterino S; Solimine S
    Prim Care Companion CNS Disord; 2017 Nov; 19(6):. PubMed ID: 29190419
    [No Abstract]   [Full Text] [Related]  

  • 6. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
    Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
    Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update.
    Beach SR; Celano CM; Sugrue AM; Adams C; Ackerman MJ; Noseworthy PA; Huffman JC
    Psychosomatics; 2018; 59(2):105-122. PubMed ID: 29275963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs and QT interval prolongation.
    Zareba W; Lin DA
    Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug induced QT prolongation and torsades de pointes.
    Yap YG; Camm AJ
    Heart; 2003 Nov; 89(11):1363-72. PubMed ID: 14594906
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antipsychotic pharmacotherapy for delirious syndromes - only temporary, symptom-oriented and considering QTc time].
    Schwerthöffer D; Förstl H; Fatke B
    MMW Fortschr Med; 2019 Jul; 161(Suppl 5):1-6. PubMed ID: 31313266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction.
    Michalets EL; Smith LK; Van Tassel ED
    Ann Pharmacother; 1998; 32(7-8):761-5. PubMed ID: 9681092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
    Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
    Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.
    Muzyk AJ; Rayfield A; Revollo JY; Heinz H; Gagliardi JP
    Drug Saf; 2012 Jul; 35(7):547-53. PubMed ID: 22702639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
    Züchner H
    Dtsch Med Wochenschr; 2002 May; 127(18):983-4. PubMed ID: 11987023
    [No Abstract]   [Full Text] [Related]  

  • 16. [QTc-prolonging drugs and the risk of sudden death].
    Reingardiene D; Vilcinskaite J
    Medicina (Kaunas); 2007; 43(4):347-53. PubMed ID: 17485963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department approach to QTc prolongation.
    Pourmand A; Mazer-Amirshahi M; Chistov S; Sabha Y; Vukomanovic D; Almulhim M
    Am J Emerg Med; 2017 Dec; 35(12):1928-1933. PubMed ID: 28855066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.
    Mukherji EH; Bauer LK; Leskov I; Januzzi JL; Tanev KS
    Am J Psychiatry; 2011 Sep; 168(9):990-1. PubMed ID: 21890808
    [No Abstract]   [Full Text] [Related]  

  • 19. QT prolongation with migraine medications.
    Evans RW; Atriham AR
    Headache; 2003; 43(7):809-10. PubMed ID: 12890141
    [No Abstract]   [Full Text] [Related]  

  • 20. Haloperidol-induced torsade de pointes.
    O'Brien JM; Rockwood RP; Suh KI
    Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.